Stepan Company
General ticker "SCL" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.3B (TTM average)
Stepan Company follows the US Stock Market performance with the rate: 6.3%.
Estimated limits based on current volatility of 1.6%: low 50.68$, high 52.20$
Factors to consider:
- Earnings expected soon, date: 2026-04-28 bmo
- Company pays dividends (quarterly): last record date 2026-03-02, amount 0.40$ (Y3.11%)
- Total employees count: 2396 (+0.3%) as of 2024
- US accounted for 55.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Raw material cost volatility, Supply chain disruptions, Execution risks, Acquisition/divestiture risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [34.98$, 55.66$]
- 2026-12-31 to 2027-12-31 estimated range: [39.05$, 60.39$]
Financial Metrics affecting the SCL estimates:
- Negative: with PPE of 26.1 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 13.61 > 12.96
- Positive: -4.72 < Operating profit margin, % of 2.95
- Negative: 0.73 < Interest expense per share per price, % of 2.41
- Positive: 42.60 < Shareholder equity ratio, % of 52.76 <= 64.25
- Positive: 5.46 < Industry operating cash flow per share per price (median), % of 5.64
- Negative: Industry earnings per price (median), % of 3.05 <= 4.54
- Positive: Industry inventory ratio change (median), % of 0.03 <= 0.31
- Positive: Inventory ratio change, % of -0.34 <= 0
- Positive: -14.24 < Investing cash flow per share per price, % of -8.19
Short-term SCL quotes
Long-term SCL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,325.77MM | $2,180.27MM | $2,332.11MM |
| Operating Expenses | $2,267.16MM | $2,109.79MM | $2,263.22MM |
| Operating Income | $58.61MM | $70.48MM | $68.90MM |
| Non-Operating Income | $-10.22MM | $-10.04MM | $-8.99MM |
| Interest Expense | $12.10MM | $14.18MM | $26.23MM |
| R&D Expense | $59.04MM | $55.67MM | $59.28MM |
| Income(Loss) | $48.39MM | $60.44MM | $59.90MM |
| Taxes | $8.19MM | $10.07MM | $13.01MM |
| Profit(Loss)* | $40.20MM | $50.37MM | $46.90MM |
| Stockholders Equity | $1,216.49MM | $1,169.93MM | $1,244.01MM |
| Inventory | $265.56MM | $288.72MM | $298.83MM |
| Assets | $2,363.35MM | $2,304.65MM | $2,357.70MM |
| Operating Cash Flow | $174.88MM | $162.05MM | $147.88MM |
| Capital expenditure | $260.33MM | $122.78MM | $122.51MM |
| Investing Cash Flow | $-258.67MM | $-116.94MM | $-89.05MM |
| Financing Cash Flow | $33.28MM | $-64.52MM | $-35.44MM |
| Earnings Per Share** | $1.77 | $2.20 | $2.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.